Dow Up0.51% Nasdaq Up0.24%

Unilife Corporation (UNIS)

-NasdaqGM
2.99 Up 0.07(2.40%) 4:00PM EST
ProfileGet Profile for:
Unilife Corporation
250 Cross Farm Lane
York, PA 17406
United States - Map
Phone: 717-384-3400
Fax: 717-384-3401
Website: http://www.unilife.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:209

Business Summary 

Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction. It also provides ReadyToGo platform of wearable injectors designed for pre-filled, disposable devices that can be worn by a patient over periods during the subcutaneous injection of therapies; LISA smart reusable auto-injector; and RITA disposable auto-injector, an ergonomic single-use product. In addition, the company offers drug reconstitution delivery systems, including AutoMix Presto, an automatic reconstitution for single-step mixing and injection; EZMix Genesis, a ventless one-step reconstitution and automatic user-controlled retraction; EZMix Engage, a one step reconstitution to attach and retract a needle; and EZMix Prodigy, a single-barrel reconstitution system with a pre-fillable syringe. Further, it provides ocular delivery systems comprising Ocu-ject for the delivery of microliter sized doses to the eye; Ocu-mix, a dual-chamber syringe platform to reconstitute or mix, and deliver various therapies into the eye with a single injection; and Depot-ject, which places a drug depot into the eye. Additionally, the company offers Micro-ject to optimize the delivery of therapies with microliter doses that are unsuited to conventional device technologies. It serves pharmaceutical and biotechnology companies. The company was founded in 2002 and is headquartered in York, Pennsylvania.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Unilife Corporation

Corporate Governance 
Unilife Corporation’s ISS Governance QuickScore as of Nov 1, 2014 is 7. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 4; Compensation: 8.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Alan D. Shortall , 60
Chairman, Chief Exec. Officer, Member of Strategic Partnerships Committee and Chief Exec. Officer of UMSL
702.00K1.84M
Mr. Dennis P. Pyers BSc, CPA, 53
Interim Chief Financial Officer, Chief Accounting Officer, VP and Controller
314.00K0.00
Dr. Ramin Mojdeh Ph.D., 52
Pres and Chief Operating Officer
733.00K0.00
Mr. Mark V. Iampietro BSc, 61
Chief Compliance Officer and VP of Corp. Quality & Regulatory Affairs
314.00K0.00
Mr. John C. Ryan J.D., 44
Sr. VP, Gen. Counsel and Sec.
52.00K0.00
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders